Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults.
about
Overview and recent advances in the treatment of neuroblastoma.An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications.Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltrationNothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapyAge dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation.Surgical resection and post-operative radiotherapy in an adult renal neuroblastoma patient with multiple bone and joint metastases: A case report.Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)Ten challenges in the management of neuroblastoma.Treatment setting, clinical trial enrollment, and subsequent outcomes among adolescents with cancer: a literature review.Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog.Clinical research on rare diseases of children: neuroblastoma.Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastoma.
P2860
Q30238693-6133197E-896B-4444-A721-C756C81A3BA1Q34093032-61B18AD2-A4F4-48AE-84EC-5DB8BF46751DQ34346730-F2827040-8422-44A1-9EB3-3B808C9A3898Q34543646-75C664CF-7DC5-4557-95F4-025930D2C984Q34711056-69BD2A85-57BD-41C5-BBFE-36D14224BBC5Q35758527-837DEA41-869A-40D7-A625-409637501ECCQ36167173-22DE68C7-AB0F-4377-9878-46DE42E9A13CQ38029366-E3EB0423-EEBA-4D9F-AE64-B5C6B9C43284Q38219435-5C80A6B3-3727-4CED-A3FA-B08E361A95ABQ38659292-D641300E-39A2-4660-9EA5-FFBEC4C49530Q38791761-3516F2C3-C011-45B0-BBD5-EB8E280F4630Q43732741-D4712ABE-CB83-4B07-9034-B05EDE94C74FQ44523074-B9F93AE2-E85F-4D73-8492-FEAD48EDAF7C
P2860
Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Response, survival, and toxici ...... ents, adolescents, and adults.
@ast
Response, survival, and toxici ...... ents, adolescents, and adults.
@en
type
label
Response, survival, and toxici ...... ents, adolescents, and adults.
@ast
Response, survival, and toxici ...... ents, adolescents, and adults.
@en
prefLabel
Response, survival, and toxici ...... ents, adolescents, and adults.
@ast
Response, survival, and toxici ...... ents, adolescents, and adults.
@en
P2093
P2860
P356
P1433
P1476
Response, survival, and toxici ...... ents, adolescents, and adults.
@en
P2093
Alexei L Polishchuk
Daphne Haas-Kogan
Katherine K Matthay
Randall Hawkins
Steven G Dubois
P2860
P304
P356
10.1002/CNCR.25987
P407
P577
2011-03-08T00:00:00Z